Compound ID | 321
Synonym(s): CS-023 | RO4908463 | R-115685
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. Penicillin-binding protein inhibitor |
| Description: | A 1-beta-methylcarbapenem stable in the presence of dehydropeptidase-1 (DHP-1) |
| Institute where first reported: | Daiichi Sankyo Pharmaceutical; Hoffman-La Roche, Switzerland |
| Year first mentioned: | 2000 |
| Highest development stage: | Phase 2 |
| Development status: | Inactive |
| Reason dropped: | Discontinued for unknown reasons |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9809656 |
| Guide to Pharmacology: | tomopenem |
| Citations: |
|